In a dual targeting approach aimed at superior targeting ability and delivery to tumor neovasculature and tumor cells, PEG-PCL nanoparticles were functionalized with RGD peptide and interleukin-13 peptide [123]. The gene discussed is IL13; the disease is neoplasm.